Hong Liu

Long-term safety and efficacy of once-daily topical brimonidine tartrate gel 0.5% for the treatment of moderate to severe facial erythema of rosacea: results of a 1-year open-label study.

Angela Moore, Steven Kempers, George J. Murakawa et al. · PubMed · 2014 · 90 citations

Topical Bt, Facial Erythema, Pharmacology +14

Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites

Hong Liu, Melissa J. Michmerhuizen, Yanbin Lao et al. · Drug Metabolism and Disposition · 2016 · 87 citations

Retrospective study of modified SMILE chemotherapy for advanced-stage, relapsed, or refractory extranodal natural killer (NK)/T cell lymphoma, nasal type

Li Yang, Hong Liu, Xiaohong Xu et al. · Medical Oncology · 2013 · 46 citations

Retrospective Study, Lymphoid Neoplasia, Medicine +8

Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials

Edward Gane, Stephen Pianko, Stuart K. Roberts et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 27 citations

Hepatic Disorders, Hepatology, Hepatitis C +13

Safety and efficacy of a fixed-dose combination regimen of grazoprevir, ruzasvir, and uprifosbuvir with or without ribavirin in participants with and without cirrhosis with chronic hepatitis C virus genotype 1, 2, or 3 infection (C-CREST-1 and C-CREST-2, part B): two randomised, phase 2, open-label trials

Eric Lawitz, John M. Vierling, Piero Luigi Almasio et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 22 citations

Fixed-dose Combination Regimen, Hepatic Disorders, Hepatology +12